This system focuses on using self-assembling genetically engineered polymeric nanoparticles formed by elastin-like recombinamers (ELRs) to deliver a small peptide inhibitor of protein kinase Akt to pancreatic cancer cells. Here, AKT1 is linked to pancreatic neoplasm.